![Adam Zong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Chen Zong is currently President at Harbour BioMed (Shanghai) Co., Ltd. and President at HBM Holdings Ltd., both positions starting in 2026.
Formerly, Dr. Zong was President & Chief Operating Officer at Seven & Eight Biopharmaceuticals, Inc. Education includes a doctorate from The Rockefeller University and an MBA from The Wharton School of the University of Pennsylvania.
Cargos activos de Adam Zong
| Empresas | Cargo | Inicio |
|---|---|---|
| HBM HOLDINGS LIMITED | Presidente | 16/04/2026 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Presidente | 16/04/2026 |
Antiguos cargos conocidos de Adam Zong.
| Empresas | Cargo | Fin |
|---|---|---|
Seven & Eight Biopharmaceuticals, Inc.
 Seven & Eight Biopharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of novel immunotherapies for cancer | Presidente | - |
Formación de Adam Zong.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
2
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
HBM Holdings Ltd.
 HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
Seven & Eight Biopharmaceuticals, Inc.
Seven & Eight Biopharmaceuticals, Inc. BiotechnologyHealth Technology Engages in research and development of novel immunotherapies for cancer | Health Technology |
- Bolsa de valores
- Insiders
- Adam Zong
